Biotoxtech Co Stock Price To Sales
| 086040 Stock | KRW 5,990 690.00 0.74% |
Biotoxtech Co fundamentals help investors to digest information that contributes to Biotoxtech's financial success or failures. It also enables traders to predict the movement of Biotoxtech Stock. The fundamental analysis module provides a way to measure Biotoxtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotoxtech stock.
Biotoxtech |
Biotoxtech Co Company Price To Sales Analysis
Biotoxtech's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Biotoxtech Price To Sales | 3.12 X |
Most of Biotoxtech's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotoxtech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Biotoxtech Co has a Price To Sales of 3.1218 times. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The price to sales for all Republic of Korea stocks is notably lower than that of the firm.
Biotoxtech Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotoxtech's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotoxtech could also be used in its relative valuation, which is a method of valuing Biotoxtech by comparing valuation metrics of similar companies.Biotoxtech is currently under evaluation in price to sales category among related companies.
Biotoxtech Fundamentals
| Return On Equity | 13.27 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 156.1 B | |||
| Shares Outstanding | 14.56 M | |||
| Shares Owned By Insiders | 26.95 % | |||
| Shares Owned By Institutions | 0.68 % | |||
| Price To Earning | 47.60 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 34.09 B | |||
| Gross Profit | 6.4 B | |||
| EBITDA | 5.67 B | |||
| Net Income | 6.98 B | |||
| Cash And Equivalents | 18.59 B | |||
| Cash Per Share | 803.72 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 47.30 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 1,604 X | |||
| Cash Flow From Operations | 4.35 B | |||
| Target Price | 15000.0 | |||
| Beta | 0.84 | |||
| Market Capitalization | 115.73 B | |||
| Total Asset | 90.74 B | |||
| Retained Earnings | (4.82 B) | |||
| Working Capital | (4.75 B) | |||
| Current Asset | 13.46 B | |||
| Current Liabilities | 18.21 B | |||
| Z Score | 34.2 | |||
| Net Asset | 90.74 B |
About Biotoxtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotoxtech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotoxtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotoxtech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |